TG Therapeutics, Inc. to Host Conference Call on Second Quarter 2013 Financial Results and Business Update

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, July 31, 2013 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX), an innovative, clinical-stage biopharmaceutical company, today announced that a conference call will be held on Friday, August 2, 2013 at 8:30 a.m. EDT to discuss results for the second quarter 2013 and provide a business outlook for the remainder of 2013. Michael Weiss, Executive Chairman and Interim Chief Executive Officer, will host the call.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC